Coronary microvascular disease Clinical Trials

13 recruitingLast updated: May 5, 2026

There are 12 actively recruiting coronary microvascular disease clinical trials across 9 countries. Studies span Not Applicable, Phase 1, Phase 4. Top locations include London, United Kingdom, Mainz, Rhineland-Palatinate, Germany, Copenhagen, Denmark. Updated daily from ClinicalTrials.gov.


Coronary microvascular disease Trials at a Glance

12 actively recruiting trials for coronary microvascular disease are listed on ClinicalTrialsFinder across 6 cities in 9 countries. The largest study group is Not Applicable with 5 trials, with the heaviest enrollment activity in London, Mainz, and Copenhagen. Lead sponsors running coronary microvascular disease studies include Johannes Gutenberg University Mainz, Henan Institute of Cardiovascular Epidemiology, and Bispebjerg Hospital.

Browse coronary microvascular disease trials by phase

Treatments under study

About Coronary microvascular disease Clinical Trials

Looking for clinical trials for Coronary microvascular disease? There are currently 13 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Coronary microvascular disease trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Coronary microvascular disease clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 112 of 12 trials

Recruiting

Coronary Flow During Rapid Heart Rates

Coronary microvascular diseaseHeart FailureCoronary Artery Disease+2 more
Imperial College London70 enrolled1 locationNCT05841199
Recruiting
Not Applicable

Self-Expanding Coronary Sinus Reducer for Treatment of Symptomatic Coronary Microvascular Dysfunction (CMD) (SERRA-I Study)

Coronary microvascular diseaseCoronary Microvascular Dysfunction
VahatiCor, Inc.30 enrolled2 locationsNCT06991322
Recruiting

Barts-MINOCA Registry

Coronary microvascular diseaseMyocardial InfarctionGender
Queen Mary University of London3,000 enrolled1 locationNCT04440761
Recruiting
Phase 1

Study Targeting Myocardial Perfusion and Symptom Relief in Women With SGLT2 Inhibitors (STRONG)

Coronary microvascular diseaseCoronary Microvascular Dysfunction (CMD)Angina Patients With Non-obstructive Coronary Artery Disease
University of Virginia150 enrolled1 locationNCT06600178
Recruiting

An Observational Study of Coronary Microvascular Disease of China

Coronary microvascular disease
Henan Institute of Cardiovascular Epidemiology500 enrolled1 locationNCT06676137
Recruiting

A Clinical Study of Fundus OCTA for the Identification of CMD

Coronary microvascular disease
Peking University First Hospital400 enrolled1 locationNCT05743140
Recruiting
Not Applicable

Impact of Exercise Training on Ischemia With Non-Obstructive Coronary Arteries (INOCA): The ExINOCA Study

Coronary microvascular diseaseCMD
Bispebjerg Hospital100 enrolled2 locationsNCT06529848
Recruiting
Phase 4

Qishenyiqi Dripping Pill for Coronary Microvascular Disease

Coronary microvascular disease
Qilu Hospital of Shandong University162 enrolled3 locationsNCT06699420
Recruiting

Multicenter Registry on Microvascular Dysfunction - Searching a New Ach Spasm Definition

Coronary microvascular diseaseCoronary Vasospasm
Johannes Gutenberg University Mainz1,000 enrolled1 locationNCT06125392
Recruiting
Not Applicable

Insulin Resistance and Coronary Microvascular Dysfunction in Patients with Myocardial Ischemia and Non-obstructive Coronary Artery Disease

Coronary microvascular diseaseInsulin ResistanceCoronary Microvascular Dysfunction
Azienda Ospedaliera Universitaria Integrata Verona40 enrolled1 locationNCT06597851
Recruiting
Not Applicable

Personalized Medicine Using Coronary Microvascular Function Measured in Patient With Percutaneous Coronary Intervention in Angina

Coronary microvascular disease
University Hospital, Grenoble280 enrolled1 locationNCT05178914
Recruiting
Not Applicable

COSIMA: COronary SInus Reducer for the Treatment of Refractory Microvascular Angina

Coronary microvascular diseaseRefractory Angina
Johannes Gutenberg University Mainz144 enrolled1 locationNCT04606459